Horizon Therapeutics Public Limited Company (HZNP) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Horizon Therapeutics Public Limited Company  (NASDAQ: HZNP)


Horizon Therapeutics Public Limited's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Horizon Therapeutics Public Limited's ROI in the second quarter of 2023?
Horizon Therapeutics Public Limited Company achieved a return on average invested assets (ROI) of 5.71 % in its second quarter of 2023, this is above HZNP's average return on investment of -20.22%.
Horizon Therapeutics Public Limited Companys investments during the 12 months ending in the second quarter of 2023 are valued at $7 billion

ROI has improved compared to 4.81% in the first quarter of 2023, due to net income growth.

Within the Healthcare sector 133 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2023 quarter, so far to 1271, from total ROI ranking in the first quarter of 2023 at 1358.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -2.63 % 0.29 % 4.02 % 14.5 % 28.09 %
Y / Y Net Income Change TTM -42.74 % -56.86 % -20.73 % 18.49 % 383.79 %
Investment (TTM) in Millions 7,852 7,640 7,619 7,583 8,062
Return On Investment (TTM) 5.71 % 4.81 % 6.69 % 7.33 % 9.71 %
HZNP's Overall Ranking # 1271 # 1358 # 1268 # 517 # 612
Seq. Investment Change TTM -0.68 % -0.88 % -0.55 % -0.55 % 2.3 %
Seq. Net Income Change TTM 17.77 % -28.68 % -9.19 % -24.93 % -11.27 %
Net Income (TTM) in Millions 438 372 521 574 765

HZNP Company Profile >> Back to HZNP Roi Comparisons >> See Annual HZNP Return On Investment



Return On Investment HZNP's Ranking
Within: No.
Industry # 50
Sector # 134
Overall # 1271

Return On Investment Statistics
High Average Low
19.83 %
-20.22 %
-248.46 %
(Sep 30 2020)   (March 31, 2014)







Financial Statements
Horizon Therapeutics Public Limited's II. Quarter Investments $ 7,852 Millions HZNP's Balance sheet
Horizon Therapeutics Public Limited's II. Quarter Income $ 127 Millions Quarterly HZNP's Income Statement
HZNP's Income by Division See HZNP's Income by Division


HZNP Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 7,619 7,791 5,197 3,713 3,099
Y / Y Investment Growth -2.21 % 49.92 % 39.97 % 19.8 % -0.6 %
Net Income in Millions 521 534 390 573 -74
Y / Y Net Income Growth -2.43 % 37.12 % -31.98 % - -
Annual Return On Investment 6.84 % 6.86 % 7.5 % 15.43 % -2.39 %


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 6.84 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HZNP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HZNP's Competitors
Subscribers only: Roi for Horizon Therapeutics Public Limited's Suppliers
Subscribers only: Return On Investment for HZNP's Customers

Other Ratios
HZNP's Roa HZNP's Inventory Turnover Ratio HZNP's Growth Rates HZNP's Dividend Statistics
HZNP's Profitability Ratios HZNP's Asset Turnover Ratio HZNP's Dividend Growth
HZNP's Roe HZNP's Valuation Ratios HZNP's Financial Strength Ratios HZNP's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
United Therapeutics Corporation  14.83 %
Omeros Corporation  14.74 %
Ufp Technologies Inc   14.68 %
Hca Healthcare Inc   14.67 %
Utah Medical Products Inc  14.42 %
Halozyme Therapeutics Inc   14.14 %
Bruker Corporation  13.98 %
Precigen Inc   13.84 %
Exelixis Inc   13.55 %
Amgen Inc   13.53 %
Amphastar Pharmaceuticals Inc   13.30 %
Pfizer Inc  13.15 %
Bristol myers Squibb Company  13.13 %
Dynavax Technologies Corporation  12.89 %
Agilent Technologies inc   12.81 %
Carlisle Companies Incorporated  12.66 %
Bio techne Corp  12.63 %
Elite Pharmaceuticals Inc   12.25 %
Biogen Inc   12.25 %
Intuitive Surgical Inc   12.07 %
Progyny Inc   11.82 %
Patterson Companies Inc   11.63 %
Abbvie Inc   11.49 %
Sep Acquisition Corp   11.19 %
Atrion Corporation  11.15 %
Gilead Sciences Inc   10.96 %
Orasure Technologies Inc  10.94 %
Alpha Pro Tech Ltd   10.50 %
Globus Medical Inc   10.50 %
Schrodinger Inc   9.80 %

Date modified: 2026-09-12T06:14:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.